Literature DB >> 10318892

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor.

C McMahon1, T Suthiphongchai, J DiRenzo, M E Ewen.   

Abstract

Cyclin D1 is overexpressed in a significant percentage of human breast cancers, particularly in those that also express the estrogen receptor (ER). We and others have demonstrated previously that experimentally overexpressed cyclin D1 can associate with the ER and stimulate its transcriptional functions in the absence of estrogen. This effect is separable from the established function of cyclin D1 as a regulator of cyclin-dependent kinases. Here, we demonstrate that cyclin D1 can also interact with the histone acetyltransferase, p300/CREB-binding protein-associated protein (P/CAF), thereby facilitating an association between P/CAF and the ER. Ectopic expression of P/CAF potentiates cyclin D1-stimulated ER activity in a dose-dependent manner. This effect is largely dependent on the acetyltransferase activity of P/CAF. These results suggest that cyclin D1 may trigger the activation of the ER through the recruitment of P/CAF, by providing histone acetyltransferase activity and, potentially, links to additional P/CAF-associated transcriptional coactivators.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318892      PMCID: PMC21868          DOI: 10.1073/pnas.96.10.5382

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

Authors:  B M Forman; K Umesono; J Chen; R M Evans
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

2.  Nuclear receptors spring into action.

Authors:  M G Parker; R White
Journal:  Nat Struct Biol       Date:  1996-02

Review 3.  Steroid hormone receptors: many actors in search of a plot.

Authors:  M Beato; P Herrlich; G Schütz
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 4.  Insights from the study of animals lacking functional estrogen receptor.

Authors:  K S Korach
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

5.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

Authors:  V Fantl; G Stamp; A Andrews; I Rosewell; C Dickson
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

6.  Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium.

Authors:  W S Shim; J DiRenzo; J A DeCaprio; R J Santen; M Brown; M H Jeng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

7.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

Authors:  P Sicinski; J L Donaher; S B Parker; T Li; A Fazeli; H Gardner; S Z Haslam; R T Bronson; S J Elledge; R A Weinberg
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

8.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

9.  A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

Authors:  Y Kamei; L Xu; T Heinzel; J Torchia; R Kurokawa; B Gloss; S C Lin; R A Heyman; D W Rose; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

Review 10.  Chromosome 11q13 markers and D-type cyclins in breast cancer.

Authors:  G Peters; V Fantl; R Smith; S Brookes; C Dickson
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more
  52 in total

1.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Transcriptional regulation by a DNA-associated form of cyclin D1.

Authors:  Frédéric Bienvenu; Benjamin Barré; Sandrine Giraud; Sylvie Avril; Olivier Coqueret
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

4.  Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.

Authors:  P L Miliani de Marval; I B Gimenez-Conti; M LaCava; L A Martinez; C J Conti; M L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

Review 6.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 7.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Authors:  J S Foster; D C Henley; A Bukovsky; P Seth; J Wimalasena
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

9.  Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.

Authors:  Amjad H Talukder; Anupama Gururaj; Sandip K Mishra; Ratna K Vadlamudi; Rakesh Kumar
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 10.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.